https://medialis.co.uk/angelman-syndrom/ 2022-06-22T08:59:58+00:00 monthly 0.2 https://medialis.co.uk/the-jandhayla-method/ 2022-06-16T08:29:20+00:00 monthly 0.2 https://medialis.co.uk/development-of-a-definition-for-medical-affairs-using-the-jandhyala-method-for-observing-consensus-opinion-among-medical-affairs-pharmaceutical-physicians/ 2022-06-16T08:28:05+00:00 monthly 0.2 https://medialis.co.uk/a-medicine-adoption-model-for-assessing-the-expected-effects-of-additional-real-world-evidence-rwe-at-product-launch/ 2022-06-16T08:25:14+00:00 monthly 0.2 https://medialis.co.uk/the-effect-of-adding-real-world-evidence-to-regulatory-submissions-on-the-breadth-of-population-indicated-for-rare-disease-medicine-treatment-by-the-european-medicines-agency/ 2022-06-16T08:24:30+00:00 monthly 0.2 https://medialis.co.uk/design-validation-and-implementation-of-the-post-acute-long-covid-19-quality-of-life-pac-19qol-instrument/ 2022-06-16T08:23:54+00:00 monthly 0.2 https://medialis.co.uk/development-and-validation-of-the-medical-affairs-pharmaceutical-physician-value-mappval-instrument/ 2022-06-16T08:20:58+00:00 monthly 0.2 https://medialis.co.uk/fgf23-and-its-role-in-x-linked-hypophosphatemia-related-morbidity/ 2022-06-16T08:19:38+00:00 monthly 0.2 https://medialis.co.uk/estimation-of-reduction-in-influenza-vaccine-effectiveness-due-to-egg-adaptation-changes-systematic-literature-review-and-expert-consensus/ 2022-06-16T08:18:48+00:00 monthly 0.2 https://medialis.co.uk/medialis-key-findings-2021/ 2022-06-16T08:17:54+00:00 monthly 0.2 https://medialis.co.uk/jandhyala-method-application/ 2022-06-16T08:16:38+00:00 monthly 0.2 https://medialis.co.uk/neutral-theory/ 2022-06-16T08:15:52+00:00 monthly 0.2 https://medialis.co.uk/5874-2/ 2022-06-16T08:14:55+00:00 monthly 0.2 https://medialis.co.uk/the-multiple-stakeholder-approach-to-real-world-evidence-rwe-generation-observing-multidisciplinary-expert-consensus-on-quality-indicators-of-rare-disease-patient-registries-rdrs/ 2022-06-16T08:14:14+00:00 monthly 0.2 https://medialis.co.uk/a-medicine-adoption-model-for-assessing-the-expected-effects-of-additional-real-world-evidence-rwe-at-product-launch-2/ 2022-06-16T08:12:47+00:00 monthly 0.2 https://medialis.co.uk/development-of-a-definition-for-real-world-evidence-using-the-jandhyala-method-for-observing-consensus-opinion-among-medical-affairs-pharmaceutical-physicians/ 2024-08-12T09:39:01+00:00 monthly 0.2 https://medialis.co.uk/6reasonstochoosemedialis/ 2024-11-14T11:37:49+00:00 monthly 0.2 https://medialis.co.uk/uncovering-the-hidden-costs-in-namd-clinics/ 2024-11-14T12:26:38+00:00 monthly 0.2 https://medialis.co.uk/payors-in-the-adoption-of-new-medicines/ 2024-11-14T13:18:41+00:00 monthly 0.2 https://medialis.co.uk/real-world-service-costs-for-neovascular-amd-clinics-in-the-united-kingdom-structured-literature-review-and-scenario-analysis/ 2024-11-14T13:38:01+00:00 monthly 0.2 https://medialis.co.uk/medialis-ltd-develops-first-long-covid-disease-specific-quality-of-life-instrument-pac-19qol/ 2024-11-14T14:20:38+00:00 monthly 0.2 https://medialis.co.uk/adaptation-and-validation-of-the-pac-19qol-specific-quality-of-life-questionnaire-for-the-spanish-population-with-long-covid/ 2024-11-19T10:07:06+00:00 monthly 0.2 https://medialis.co.uk/a-protocol-for-an-international-multicenter-prospective-non-interventional-observational-registry-for-patients-with-hypertriglyceridemia/ 2024-11-19T14:45:46+00:00 monthly 0.2 https://medialis.co.uk/development-validation-and-implementation-of-the-medical-affairs-pharmaceutical-physician-work-related-quality-of-life-instrument/ 2024-11-19T10:10:23+00:00 monthly 0.2 https://medialis.co.uk/commercial-impact-of-adding-real-world-evidence-to-clinical-trials-at-regulatory-approval-a-markovian-like-transition-model/ 2024-11-19T09:56:40+00:00 monthly 0.2 https://medialis.co.uk/observed-consensus-on-research-priorities-for-the-hypertriglyceridemia-patient-registry/ 2024-11-19T14:48:54+00:00 monthly 0.2 https://medialis.co.uk/development-of-a-definition-for-real-world-evidence-using-the-jandhyala-method-for-observing-consensus-opinion-among-medical-affairs-pharmaceutical-physicians-2/ 2024-11-19T15:02:10+00:00 monthly 0.2 https://medialis.co.uk/observing-expert-opinion-of-medical-affairs-pharmaceutical-physicians-on-the-value-of-their-clinical-experience-to-the-pharmaceutical-industry-using-the-jandhyala-method/ 2024-11-19T15:08:56+00:00 monthly 0.2 https://medialis.co.uk/a-simple-core-dataset-for-triglyceride-induced-acute-pancreatitis/ 2024-11-19T15:14:35+00:00 monthly 0.2 https://medialis.co.uk/real-world-service-costs-for-neovascular-amd-clinics-in-the-united-kingdom-structured-literature-review-and-scenario-analysis-2/ 2024-11-21T10:11:52+00:00 monthly 0.2 https://medialis.co.uk/the-association-between-influenza-vaccine-effectiveness-and-egg-based-manufacturing-technology-literature-review-and-us-expert-consensus/ 2024-11-21T10:22:51+00:00 monthly 0.2